Cargando…
Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis
Polarisation-sensitive optical coherence tomography (PS-OCT) offers a novel, non-invasive method of assessing skin fibrosis in the multisystem disease systemic sclerosis (SSc) by measuring collagen retardance. This study aimed to assess retardance as a biomarker in SSc. Thirty-one patients with SSc...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861061/ https://www.ncbi.nlm.nih.gov/pubmed/35190594 http://dx.doi.org/10.1038/s41598-022-06783-7 |
_version_ | 1784654804352499712 |
---|---|
author | Marjanovic, E. J. Sharma, V. Smith, L. Pinder, C. Moore, T. L. Manning, J. B. Dinsdale, G. Berks, M. Newton, V. L. Wilkinson, S. Dickinson, M. R. Herrick, A. L. Watson, R. E. B. Murray, A. K. |
author_facet | Marjanovic, E. J. Sharma, V. Smith, L. Pinder, C. Moore, T. L. Manning, J. B. Dinsdale, G. Berks, M. Newton, V. L. Wilkinson, S. Dickinson, M. R. Herrick, A. L. Watson, R. E. B. Murray, A. K. |
author_sort | Marjanovic, E. J. |
collection | PubMed |
description | Polarisation-sensitive optical coherence tomography (PS-OCT) offers a novel, non-invasive method of assessing skin fibrosis in the multisystem disease systemic sclerosis (SSc) by measuring collagen retardance. This study aimed to assess retardance as a biomarker in SSc. Thirty-one patients with SSc and 27 healthy controls (HC) underwent PS-OCT imaging. ‘Skin score’ was assessed by clinical palpation (0–3 scale). A subset of ten patients and ten age/sex-matched HC had a biopsy and longitudinal imaging. Histological assessment included quantification of epidermal thickness, collagen content (to assess fibrosis) and matrix metalloproteinase (MMP) activity (in situ zymography). PS-OCT images were assessed for epidermal thickness (structure) and fibrosis (retardance). Positive correlation was observed between epidermal thickness as measured by histology and structural PS-OCT (r = 0.79; p < 0.001). Retardance was: HC mean 0.21 (SD 0.21) radian/pixel; SSc skin score 0, 0.30 (0.19); skin score 1, 0.11 (0.16); skin score 2, 0.06 (0.12); skin score 3, 0.36 (0.35). Longitudinal retardance decreased at one-week across groups, increasing at one-month for HC/skin score 0–1; HC biopsy site retardance suggests scarring is akin to fibrosis. Relationships identified between retardance with both biopsy and skin score data indicate that retardance warrants further investigation as a suitable biomarker for SSc-related fibrosis. |
format | Online Article Text |
id | pubmed-8861061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-88610612022-02-22 Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis Marjanovic, E. J. Sharma, V. Smith, L. Pinder, C. Moore, T. L. Manning, J. B. Dinsdale, G. Berks, M. Newton, V. L. Wilkinson, S. Dickinson, M. R. Herrick, A. L. Watson, R. E. B. Murray, A. K. Sci Rep Article Polarisation-sensitive optical coherence tomography (PS-OCT) offers a novel, non-invasive method of assessing skin fibrosis in the multisystem disease systemic sclerosis (SSc) by measuring collagen retardance. This study aimed to assess retardance as a biomarker in SSc. Thirty-one patients with SSc and 27 healthy controls (HC) underwent PS-OCT imaging. ‘Skin score’ was assessed by clinical palpation (0–3 scale). A subset of ten patients and ten age/sex-matched HC had a biopsy and longitudinal imaging. Histological assessment included quantification of epidermal thickness, collagen content (to assess fibrosis) and matrix metalloproteinase (MMP) activity (in situ zymography). PS-OCT images were assessed for epidermal thickness (structure) and fibrosis (retardance). Positive correlation was observed between epidermal thickness as measured by histology and structural PS-OCT (r = 0.79; p < 0.001). Retardance was: HC mean 0.21 (SD 0.21) radian/pixel; SSc skin score 0, 0.30 (0.19); skin score 1, 0.11 (0.16); skin score 2, 0.06 (0.12); skin score 3, 0.36 (0.35). Longitudinal retardance decreased at one-week across groups, increasing at one-month for HC/skin score 0–1; HC biopsy site retardance suggests scarring is akin to fibrosis. Relationships identified between retardance with both biopsy and skin score data indicate that retardance warrants further investigation as a suitable biomarker for SSc-related fibrosis. Nature Publishing Group UK 2022-02-21 /pmc/articles/PMC8861061/ /pubmed/35190594 http://dx.doi.org/10.1038/s41598-022-06783-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Marjanovic, E. J. Sharma, V. Smith, L. Pinder, C. Moore, T. L. Manning, J. B. Dinsdale, G. Berks, M. Newton, V. L. Wilkinson, S. Dickinson, M. R. Herrick, A. L. Watson, R. E. B. Murray, A. K. Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis |
title | Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis |
title_full | Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis |
title_fullStr | Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis |
title_full_unstemmed | Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis |
title_short | Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis |
title_sort | polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861061/ https://www.ncbi.nlm.nih.gov/pubmed/35190594 http://dx.doi.org/10.1038/s41598-022-06783-7 |
work_keys_str_mv | AT marjanovicej polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT sharmav polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT smithl polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT pinderc polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT mooretl polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT manningjb polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT dinsdaleg polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT berksm polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT newtonvl polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT wilkinsons polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT dickinsonmr polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT herrickal polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT watsonreb polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis AT murrayak polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis |